BioMed Central | Articles which cite: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab.

home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central

Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab.
Baraliakos X, Listing J, Brandt J, Zink A, Alten R, Burmester G, Gromnica-Ihle E, Kellner H, Schneider M, Sörensen H, Zeidler H, Rudwaleit M, Sieper J, Braun J
Arthritis Res Ther 2005, 7:R439-44
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]

printer friendly

to [Help]

BioMed Central articles that cite the above article:

Research article

Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis
van der Heijde DM, Revicki DA, Gooch KL, Wong RL, Kupper H, Harnam N, Thompson C, Sieper J, the ATLAS Study Group
Arthritis Research & Therapy 2009, 11:R124 (17 August 2009)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

Review

Correction

Correction: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
Baraliakos X, Listing J, Brandt J, Zink A, Alten R, Burmester G, Gromnica-Ihle E, Kellner H, Schneider M, Sörensen H, Zeidler H, Rudwaleit M, Sieper J, Braun J
Arthritis Research & Therapy 2005, 7:113 (23 March 2005)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

This article is also cited by a further 6 articles in PubMed Central

You can also check ISI Web of Science for additional citations (subscription required)

printer friendly

to [Help]